Logo image
Inhibition of Platelet Aggregation by Activation of Platelet Intermediate Conductance Ca2+-Activated Potassium Channels
Journal article   Open access   Peer reviewed

Inhibition of Platelet Aggregation by Activation of Platelet Intermediate Conductance Ca2+-Activated Potassium Channels

Valentina Back, Amir Asgari, Aleksandra Franczczak, Max Saito, Diego Castaneda Zaragoza, Shaun Sandow, Frances Plane and Paul Jurasz
Journal of Thrombosis and Haemostasis, Vol.20(11), pp.2587-2600
2022
PMID: 35867883
pdf
Inhibition of Platelet Aggregation by Activation of Platelet Intermediate Conductance Ca2Activated Potassium Channels1.34 MBDownloadView
Accepted Version Open Access
url
https://doi.org/10.1111/jth.15827View
Published Version

Abstract

platelets platelet aggregation intermediate conductance Ca2+-activated K+ channels nitric oxide thrombosis
Background: Within the vasculature platelets and endothelial cells play crucial roles in hemostasis and thrombosis. Platelets, like endothelial cells, possess intermediate conductance Ca2+-activated K+ (IKCa) channels and generate nitric oxide (NO). While NO limits platelet aggregation, the role of IKCa channels in platelet function and NO-generation has not yet been explored. Objectives: We investigated whether IKCa channel activation inhibits platelet aggregation, and per endothelial cells, enhances platelet NO production. Methods: Platelets were isolated from human volunteers. Aggregometry, confocal microscopy and a novel flow chamber model, the Quartz Crystal Microbalance (QCM) were used to assess platelet function. Flow cytometry was used to measure platelet NO production, calcium signaling, membrane potential, integrin αIIb/β3 activation, granule release, and procoagulant platelet formation. Results: Platelet IKCa channel activation with SKA-31 inhibited aggregation in a concentration-dependent manner, an effect reversed by the selective IKCa channel blocker TRAM-34. The QCM model along with confocal microscopy demonstrated that SKA-31 inhibited platelet aggregation under flow conditions. Surprisingly, IKCa activation by SKA-31 inhibited platelet NO generation, but this could be explained by a concomitant reduction in platelet calcium signaling. IKCa activation by SKA-31 also inhibited dense and alpha-granule secretion and integrin αIIb/β3 activation, but enhanced platelet phosphatidylserine surface exposure as a measure of procoagulant response. Conclusions: Platelet IKCa channel activation inhibits aggregation by reducing calcium-signaling and granule secretion, but not by enhancing platelet NO generation. IKCa channels may be novel targets for the development of anti-platelet drugs that limit atherothrombosis, but not coagulation.

Details

Metrics

1 File views/ downloads
75 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Web Of Science research areas
Hematology
Peripheral Vascular Disease

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs from InCites

Logo image